Xilio Therapeutics (XLO) Prepaid Assets (2020 - 2026)

Xilio Therapeutics (XLO) has 7 years of Prepaid Assets data on file, last reported at $3.9 million in Q1 2026.

• For the quarter ending Q1 2026, Prepaid Assets fell 6.13% year-over-year to $3.9 million; the trailing twelve-month figure through Mar 2026 stood at $3.9 million (down 6.13% YoY), and the FY2025 full-year result was $2.5 million, down 49.5% from the prior year.
• Prepaid Assets grew to $3.9 million in Q1 2026, from $2.5 million in the prior quarter.
• In the past five years, Prepaid Assets ranged from a high of $5.2 million in Q1 2024 to a low of $2.0 million in Q3 2024.
• A 5-year average of $3.6 million and a median of $3.6 million in 2022 frame the typical range for Prepaid Assets.
• Across the five-year window, Prepaid Assets surged 48.47% in 2023 and sank 56.46% in 2024, its largest moves.
• Tracing XLO's Prepaid Assets over 5 years: stood at $4.1 million in 2022, then declined by 16.74% to $3.4 million in 2023, then jumped by 44.41% to $4.9 million in 2024, then sank by 49.5% to $2.5 million in 2025, then soared by 55.21% to $3.9 million in 2026.
• Business Quant data shows XLO's Prepaid Assets at $3.9 million in Q1 2026, $2.5 million in Q4 2025, and $2.8 million in Q3 2025.